In the context of HNSCC, EGFR targeting with CAR-T causes gastrointestinal, respiratory, hematological, and immunological toxicity due to the ubiquity of EGFR in normal tissues. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.